A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
Clinical trial NCT03404115 · COMPLETED
Trial details
- NCT number
- NCT03404115
- Sponsor
- Aldeyra Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-02
- Primary completion
- 2018-07-11
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.